Received Apr 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
Inappropriate schedule of vaccine administered; no adverse event; This Spontaneous report was received from Pharmacist and referred to a 39 -year-old Female patient. The patient's medical history, past medications and concomitant medications were not reported. In Mar-2025, the patient started therapy with Human Papillomavirus 9-valent vaccine (GARDASIL 9), recombinant suspension for injection 0.5 mL (lot #, expiration date, route of administration and anatomical location were not provided) for prophylaxis and has not received the second dose yet (Inappropriate schedule of vaccine administered). No adverse event was reported.